Matching slides 11,828
Current window 5,491-5,520
Pages 395
Rows per page 30
Slide function: Show Tractionclear collectionreset all

Slide function

5,491-5,520 of 11,828

filter-aware
22
The chart compares High vs Low Fidelity models with and without pretraining across different training data sizes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
16
The slide uses a combination of a bar chart, two donut charts, and a KPI table to demonstrate business health.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
18
The slide uses a combination of a bar chart for historical growth, a donut chart for asset allocation, and a KPI table for business highlights.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
20
The slide uses a line chart to demonstrate performance stability relative to a benchmark.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
23
The slide uses a two-column layout to contrast criteria for Wealth Management vs Asset Management acquisitions.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
25
The slide highlights ESG integration and specific dollar-value commitments to impact strategies.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
The slide uses three distinct bar charts to illustrate asset growth, revenue composition, and margin expansion.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Financials1 hit
29
The slide uses stacked bar charts to show segment contributions (Asset Management vs Wealth Management) to key financial metrics.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Financials1 hit
20
Uses a hub-and-spoke diagram to illustrate the ecosystem.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
The chart demonstrates the efficacy of the ApolloMed tech-enabled ecosystem in improving patient engagement metrics.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a combination of grouped bar charts for clinical outcomes and stacked bar charts for demographic segmentation.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses two bar charts to show performance metrics against benchmarks.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
26
The slide uses a three-part structure: historical performance ranking, a comparative bar chart of savings, and a forward-looking opportunity statement.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction1 hit
28
The slide highlights both historical performance (25+ years) and current operational reach.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Growth StrategyLoop · Quick Win Big Bet1 hit
32
The slide uses two bar charts side-by-side to demonstrate financial performance.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
12
Includes clinical trial data visualization and product summary table.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The chart uses a dot plot to show individual patient CADSS scores over time across three cohorts (30mg, 60mg, Placebo).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
CIAS likely refers to Cognitive Impairment Associated with Schizophrenia.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
05
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
13
The chart uses a horizontal bar format to represent progress through clinical phases. Several programs are marked with AstraZeneca partnership dates.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
14
The slide uses a split-layout with a dark sidebar for partnership specifics and a light main area for strategic benefits.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
15
The slide uses a list-based framework to demonstrate the 'Novel, Rapid, Effective' nature of their AI-driven discovery process.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
35
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
39
The slide uses a flowchart to illustrate the adaptive clinical trial design.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
33
The chart highlights the efficacy of CBD in reducing anxiety during the 'A' (Anticipation) and 'S' (Speaking) phases of the challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
35
The chart highlights the performance phase where the PH94B group shows a downward trend in distress compared to the placebo group.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
37
The chart highlights the 'Speech' phase with a box. SUDS is a standard clinical measure for anxiety.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
43
The table lists 13 rows, though the title mentions 12 trials; likely one trial is split or there is a discrepancy in the count.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
47
The slide uses a bar chart to compare placebo vs BNC210 across two metrics: total number of symptoms and symptom intensity.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit